Tender detail
Non-exclusive rebate agreement for granisetron-containing medicines
Summary
The tender concerns the conclusion of a non-exclusive rebate agreement for medicines containing granisetron for the period 1 August 2026 to 31 July 2028, with an option to extend the contract once by 12 months. DAK-Gesundheit intends to conclude agreements with as many interested pharmaceutical companies as possible. Bidders should note that the agreement will end automatically when an exclusive contract enters into force.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.